Blood-Based Biomarkers Aid in Closing Diagnostic Gap in Dementia

Blood-based biomarkers are improving the accuracy of dementia diagnoses by providing more specific information beyond vague clinical assessments. However, experts emphasize that these tests should be used only after a comprehensive clinical evaluation in patients showing objective cognitive impairment.

Originally published by gnews